Excerpt from Karen Ring‘s blogpost at CIRM: How do you go from basic stem cell research to cures for patients? We ask this question everyday at CIRM, and we’re not alone in our tireless pursuit to find answers to this challenging question. In fact, two leaders on different sides of the stem cell arena – […]
PAIN Q&A – The Big3Bio Interview and Event Preview
/ big4bio
Hydra Biosciences, a Cambridge company leading the field in Transient Receptor Potential (TRP) ion channel modulation for pain, inflammation, renal disease, anxiety and pulmonary disease, is hosting a panel discussion entitled “PAIN: a conversation.” Taking place at The Liberty Hotel in Boston from 6 p.m. to 9 p.m. on Thursday, Oct. 22, the event will […]
Part 2 of Q&A with CLSA CEO Sara Radcliffe
/ big4bio
Note: Ahead of the BIO Investor Forum in San Francisco, Big3Bio is combining its Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe (part 1 here) with mendelspod. This video feature will run with chapter updates every day of this week. Chapter 1: CLSA – California’s first statewide trade group for biotech Chapter […]